首页> 外文OA文献 >Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes.
【2h】

Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes.

机译:[3H] -senktide与豚鼠回肠纵向肌肉-肠系膜神经丛和大脑皮质膜中NK3速激肽受体结合的药理分析。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The binding properties and pharmacological specificity of the selective NK3 tachykinin receptor agonist [3H))-senktide [( 3H]-succinyl[Asp6,MePhe8] substance P (6-11] have been examined in homogenates of guinea-pig ileum longitudinal muscle-myenteric plexus (LM/MP) and cerebral cortex. 2. Scatchard analysis of saturation binding studies in guinea-pig ileum LM/MP and cerebral cortex membranes indicated that [3H]-senktide bound to a single site with apparent high affinity, KD = 2.21 +/- 0.65 nM; Bmax = 13.49 +/- 0.04 fmol mg-1 protein in ileum and KD = 8.52 +/- 0.45 nM; Bmax = 76.3 +/- 1.6 fmol mg-1 protein in cortex (values are means +/- ranges; n = 2). 3. The pharmacological profile for tachykinins and analogues in displacing [3H]-senktide from ileum membranes was: [MePhe7] neurokinin B greater than neurokinin B (NKB) congruent to senktide greater than eledoisin greater than substance P (SP) greater than neurokinin A(NKA) greater than physalaemin greater than [Sar9,Met(O2)11]SP greater than [Nle10]NKA(4-10) = [Glp6,L-Pro9]-SP(6-11) greater than substance P methyl ester, consistent with [3H]-senktide binding to an NK3 subtype of tachykinin receptor. A similar rank order of affinity was obtained for these peptides in displacing [3H]-senktide from cortex membranes. 4. Several tachykinin receptor agonists were tested for their ability to displace [3H]-senktide from ileal and cortical NK3 binding sites and were found to be either weak displacers (pIC50 less than 5.00) or inactive.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:1.在豚鼠回肠纵向匀浆中检查了选择性NK3速激肽受体激动剂[3H])-senktide [[3H]-琥珀酰[Asp6,MePhe8]物质P(6-11)的结合特性和药理特异性。 2.豚鼠回肠LM / MP和大脑皮层膜的饱和结合研究的Scatchard分析表明[3H] -senktide以明显的高亲和力结合到单个位点, KD = 2.21 +/- 0.65 nM; Bmax =回肠中的13.49 +/- 0.04 fmol mg-1蛋白和KD = 8.52 +/- 0.45 nM; Bmax =皮层中的76.3 +/- 1.6 fmol mg-1蛋白(值为表示+/-范围; n = 2)3.速激肽和类似物从回肠膜置换[3H] -senktide的药理学特征是:[MePhe7]神经激肽B大于神经激肽B(NKB),而senktide大于eledoisin。大于P物质(SP)大于神经激肽A(NKA)大于physalaemin大于[Sar9,Met(O2)11] SP油脂[Nle10] NKA(4-10)= [Glp6,L-Pro9] -SP(6-11)大于P物质甲酯,这与[3H] -senktide与速激肽受体的NK3亚型结合相一致。在从皮质膜上置换[3H] -senktide时,这些肽获得了相似的亲和力等级。 4.测试了几种速激肽受体激动剂从回肠和皮层NK3结合位点置换[3H] -senktide的能力,发现它们是弱置换子(pIC50小于5.00)或无活性。(摘要截短了250字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号